ARCHIVES

FDA Says ImClone Data Insufficient To Evaluate Colorectal Cancer Drug C225.

This article is from The Cancer Letter archive.

Vol. 28 No. | March 8, 2002

Download PDF Visit The Full Archive

Related Articles

NCI’s Drug Screen Tests 400 Agents A Week; Recompetition Of Contracts Approved

February 26, 1993

Senate Passes Budget; Broder; Fiscal 93 Great Year – Not

September 25, 1992

NTP Plans Look At Radiation, Viruses, In Carcinogen Report.

July 27, 2001

Arthur James, Ohio Founder Of Research Institute, Dead.

October 26, 2001

NCAB Defends Organ Site Program, But DeVita Still Plan to Discuss It With Cancer Panel

October 17, 1980

ONS Meeting Again With ASCO And AACR In San Francisco

April 28, 1989